Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient.
Bjorang
Ola
O
Department of Pathology, National University Hospital, Oslo, Norway. ola.bjorang@rikshospitalet.no
Tveitan
Hilde
H
Midtvedt
Karsten
K
Broch
Lars U
LU
Scott
Helge
H
Andresen
Per A
PA
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001739:BK Virus; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D016030:Kidney Transplantation / Q000009:adverse effects; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D027601:Polyomavirus Infections / Q000188:drug therapy* / Q000209:etiology* / Q000821:virology; D014412:Tumor Virus Infections / Q000188:drug therapy* / Q000209:etiology* / Q000821:virology
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir